RxDoctor Payments DataLook up a doctor →

Gaurav Jain, MD

Neurological Surgery · Wynnewood, PANPI 1912206301

Payments from drug & device makers

$599,250in general payments, 2019–2025

Across 882 payments — averaging $679.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$534K
  • Stryker$23K
  • Globus Medical$21K
  • Si-bone, Inc.$4K
  • Nevro Corp.$2K
  • VB Spine LLC$2K
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alphatec Spine, Inc87$533,933
Stryker214$23,281
Globus Medical75$21,404
Si-bone, Inc.19$3,701
Nevro Corp.43$2,423
VB Spine LLC13$1,847
Integrity Implants Inc.13$1,432
Abbott24$723
Spinal Elements, Inc.6$602
AbbVie26$548
Spineology Inc.3$485
Medtronic6$396
UCB, Inc.21$373
Providence Medical Technology, Inc.2$356
Merz Pharmaceuticals, LLC15$355
Teva Pharmaceuticals USA, Inc.21$319
MDD US Operations, LLC13$315
Lilly USA, LLC18$315
Johnson & Johnson(2 entities)16$313
Upsher-smith Laboratories LLC15$303
Sumitomo Pharma America, Inc.10$257
AstraZeneca(2 entities)13$256
Amneal Pharmaceuticals LLC12$252
Acorda Therapeutics, Inc13$251
Integrity Implants Inc. Dba Accelus2$249
Ulrich Medical USA, Inc.2$246
Pfizer10$230
Amgen10$216
Eisai Inc.8$199
Takeda Pharmaceuticals U.S.A., Inc.8$198
Acadia Pharmaceuticals Inc11$195
Sunovion Pharmaceuticals Inc.10$193
EMD Serono, Inc.7$176
Biohaven Pharmaceutical Holding Company Ltd.8$170
Neurocrine Biosciences, Inc.7$158
CSL Behring5$154
SK Life Science, Inc.8$147
Cerapedics Inc.2$146
Merz North America, Inc.8$140
Zimvie Inc.1$131
Centinel Spine, LLC1$121
Madrigal Pharmaceuticals1$117
Lundbeck LLC5$96
Zimmer Biomet2$96
4web, Inc.1$90
Icotec Medical Inc.1$82
Averitas Pharma Inc.4$76
Biogen4$73
DJO, LLC1$69
Orthofix Medical, Inc.3$66
Jazz Pharmaceuticals Inc.4$65
Biohaven Pharmaceuticals, Inc.3$55
Avanir Pharmaceuticals, Inc.3$52
Sanofi3$50
Banner Life Sciences, LLC3$49
Promius Pharma LLC3$46
Alnylam Pharmaceuticals Inc.2$46
Bausch Health US, LLC2$44
Argenx US, Inc.2$43
Adamas Pharmaceuticals, Inc.2$43

How this compares

$599,250 in reported general payments places this provider in the 95th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$420,834
Medicare patients
626
Services billed
1,458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Wynnewood

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →